Abstract
Hyperglycemia is a frequent metabolic accompaniment of stress, and it is produced by a synergistic stimulatory action of glucagon and catecholamines on glucose production and an inhibitory action of catecholamines on insulin secretion and peripheral glucose utilization. Stress-induced hyperglycemia is most likely adaptive in function for, because the brain receives its energy from circulating glucose, increased metabolic fuel is required during times of stress for normal brain activity. However, if the rise in glucose levels is excessive, deleterious consequences are likely to ensue; glucoregulatory mechanisms most probably also evolved in order to reduce these pathologically elevated sugar concentrations and ensure survival of the organism.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Akers, R. F., & Routtenberg, A. (1984). Brain protein phosphorylation in vitro: Selective substrate action of insulin. Life Science, 35, 809–813.
Albert, P. R., Wolfson, G., & Tashjian, A. H. (1988). Diacylglycerol increases cytosolic free Ca2+ concentration in rat pituitary cells. Relationship to thyrotropin-releasing hormone action. Journal of Biol. Chemistry, 262, 6577–6581.
Amir, S. (1985/1986). Thyrotropin-releasing hormone reverses morphine-induced hyperglycemia in mice. Alcohol and Drug Research, 6, 147.
Amir, S. (1986a). In J. W. Holaday, H. Loh, A. Herz & P.-Y. Law (Eds.), Advances in endogenous and exogenous opioid peptides. NIDA Research Monographs, 75, 375–379.
Amir, S. (1986b). Endorphins contribute to loss of glucose homeostasis in anaphylactic shock. In J. W. Holaday, H. Loh, A. Herz & P.-Y. Law (Eds.), Advances in endogenous and exogenous opioid peptides. NIDA Research Monographs, 75, 371–374.
Amir, S. (1988a). Thyrotropin-releasing hormone (TRH) blocks glucagon-induced hyperglycemia in mice: Dissociation of the hyperglycemic and pituitary actions of TRH. Brain Research, 455, 201–203.
Amir, S. (1988b). TPA (12–0-tetradecanoylphorbol-13-acetate) enhances the central hypoglycemic action of thyrotropin-releasing hormone in mice. Brain Research, 450, 369–372.
Amir, S., & Butler, P. D. (1988). Thyrotropin-releasing hormone blocks neurally-mediated hyperglycemia through central action. Peptides, 9, 31–35.
Amir, S., Harel, M., & Rivkind, A. I. (1987). Thyrotropin-releasing hormone potently reverses epinephrine-induced hyperglycemia in mice. Brain Research, 435, 112–122.
Amir, S., & Jackson, I. M. D. (1988). Immunological blockade of endogenous thyrotropin-releasing hormone impairs recovery from hyperglycemia in mice. Brain Research., 462, 160–162.
Amir, S., & Rivkind, A. I. (1988). Prevention of clonidine-stimulated hyperglycemia by thyrotropin-releasing hormone. Peptides, 9, 527–531.
Amir, S., Rivkind, A. I., & Harel, M. (1985a). Central thyrotropin-releasing hormone induced systemic hypoglycemia in mice. Society for Neuroscience Abstracts, 11, 885.
Amir, S., Rivkind, A. I., & Harel, M. (1985b). Central thyrotropin-releasing hormone elicits systemic hypoglycemia in mice. Brain Research, 344, 387–391.
Amir, S., & Shechter, Y. (1987). Centrally-mediated hypoglycemic effect of insulin: Apparent involvement of specific insulin receptors. Brain Research, 418, 152–156.
Amir, S., & Shechter, Y. (1988). Apparent involvement of protein kinase C in the central glucoregulatory action of insulin. Brain Research, 450, 272–279.
Arancibia, S., Tapia-Arancibia, L., Assenmacher, I., & Astier, H. (1983). Neuroendocrinology, 37, 225–228.
Beloff-Chain, A., Edwardson, J. A., & Hawthorn, J. (1975). Influence of the pituitary gland on insulin secretion in the genetically obese (ob/ob) mouse. Journal of Endocrinology, 65, 109–116.
Bobbioni, E., & Jeanrenaud, B. (1983). A rat hypothalamic extract enhances insulin secretion in vitro. Endocrinology, 113, 1958–1962.
Brouwer, G. H., Lamptey, M. S., & Martin, J. M. (1982). Isolation and partial characterization of insulinglucagon liberation from bovine hypothalamus. Life Science, 30, 703–710.
Brown, M. (1981a). Neuropeptides: Central nervous system effects on nutrient metabolism. Diabetologia, 20, 299–304.
Brown, M. (1981b). Thyrotropin releasing factor: A putative CNS regulator of the autonomic nervous system. Life Sciences, 28, 1789–1795.
Butler, P. D., & Amir, S. (1986). Thyrotropin-releasing hormone blocks stress-induced hyperglycemia in mice. Society of Neuroscience Abstracts, 12, 219.
Dolva, L. O., Hanssen, K. F., Flaten, O., Hanssen, L. E., & von Schenk, H. (1983). The effect of thyrotropin-releasing hormone (TRH) on pancreatic hormone secretion in normal subjects. Acta Endocrinol., 102, 224–230.
Drust, D. S., & Martin, F. J. (1984). Thyrotropin-releasing hormone rapidly activates protein phosphorylation in GH3 pituitary cells by a lipid-linked, protein kinase C-mediated pathway. Journal of Biol. Chemistry, 259, 14520–14530.
Dufy, B., Jaken, S., & Barker, J. L. (1987). Intracellular Ca2+-dependent protein kinase C activation mimics delayed effects of thyrotropin-releasing hormone on clonal pituitary cell excitability. Endocrinology, 121, 793–802.
Fain, J. N. (1984). Insulin secretion and action. Metabolism, 33, 672–679.
Frohman, L. A. (1983). CNS peptides and glucoregulation. Annual Review of Physiology, 45, 95–107.
Genuth, S., & Leibovits, H. E. (1965). Stimulation of insulin release by corticotropin. Endocrinology, 65, 109–116.
Gonzalez, C, Montoya, E., & John, T. (1980). Effect of streptozotocin on the hypothalamic-pituitary-thyroid axis in the rat. Endocrinology, 107, 2099–2103.
Griffiths, E. C. (1985). Thyrotropin-releasing hormone: Endocrine and central effects. Psychoneuroendocrinology, 10, 225–235.
Grodsky, G. M. (1970). Insulin and the pancreas. Vitam. Horm., 28, 37–101.
Harris, A. R. C., Christianson, D., Smith, M. S., Fang, S. L., Braverman, L. E., & Vegenakis, A. G. (1978). The physiological role of thyrotropin- releasing hormone in the regulation of thyroid stimulating hormone and prolactin secretion in the rat. Journal of Clinical Investigation, 61, 441–448.
Hill, D. E., Mayes, S., DiBattista, D., Lockhart-Ewart, R., & Martin, J. M. (1977). Hypothalamic regulation of insulin release in Rhesus monkeys. Diabetes, 26, 726–731.
Idahl, L. A., & Martin, J. M. (1971). Stimulation of insulin release by a ventrolateral hypothalamic factor. Journal of Endocrinology, 51, 601–602.
Iguchi, A., Sakamoto, N., & Burleson, P. D. (1983). The effects of neuropeptides on glucoregulation. Advances in Metabolic Disorders, 10, 421–434.
Jackson, I. M. D. (1982). Thyrotropin-releasing hormone. New England Journal of Medicine, 306, 145–155.
Kabayama, Y., Kato, Y., Tojo, K., Shimatsu, A., Ohta, H., & Imura, N. (1985). Central effects of DN 1417, a novel TRH analog, on plasma glucose and catecholamines in conscious rats. Life Sciences, 36, 1287–1294.
Kardon, F., Marcus, R. J., Winokur, A., & Utiger, R. D. (1977). Thyrotropin-releasing hormone content of rat brain and hypothalamus: Results of endocrine and pharmacologic treatments. Endocrinology, 100, 1604–1609.
Kato, Y., & Kanno, T. (1983). Thyrotropin-releasing hormone injected intracerebroventricularly in the rat stimulates exocrine pancreatic secretion via the vagus nerve. Regul. Peptides, 7, 347–356.
Knudtzon, J. (1981). Thyrotropin-releasing factor: A putative CNS regulator of the autonomic nervous system. Hormone Metabol. Research, 13, 371–375.
Knudtzon, J. (1985). Involvement of the autonomic nervous system in the in vivo TRH-induced increases in the plasma levels of glucagon, insulin and glucose in rabbits. Hormone Metabol. Research, 17, 53–57.
Kolesnick, R. N. (1987). Thyrotropin-releasing hormone and phorbol esters induce phosphatidylcholine synthesis in GH3 pituitary cells. Evidence for stimulation via protein kinase C. Journal Biol. Chem., 262, 14525–14530.
Kraus-Friedman, N. (1984). Hormonal regulation of hepatic gluconeogenesis. Physiology Review, 64, 170–258.
Kuzuya, T. (1962). Regulation of insulin secretion by the central nervous system. II. The role of the hypothalamus and the pituitary gland upon insulin secretion. Journal of the Japanese Society of Internal Medicine, 51, 65–74.
Leung, Y., Guansing, A. R., Ajlouni, K., Hagen, T. C, Rosenfeld, P. S., & Barboriak, J. J. (1975). The effect of hypoglycemia on hypothalamic thyrotropin-releasing hormone (TRH) in the rat. Endocrinology, 97, 380–384.
Miller, R. E. (1981). Pancreatic neuroendocrinology: Peripheral neural mechanisms in the regulation of the islets of Langerhans. Endocrine Review, 2, 471–494.
Mitsuma, T., & Nogimori, T. (1982). Effects of streptozotocin-induced diabetes mellitus on hypothalamic-pituitary-thyroid axis in rats. Endocrinol. Japon., 29, 695–700.
Pastor, R. M., & John, T. (1983). Peripheral metabolism and secretion rate of thyrotropin in streptozotocin-diabetic rats. Endocrinology, 112, 1454–1459.
Rohner-Jeanrenaud, F., Bobbioni, E., Ionescu, E., Sauter, J. F., & Jeanrenaud, B. (1983). Central nervous system regulation of insulin secretion. Advances in Metabolic Disorders, 10, 193–220.
Shen, D. C., Lin, M. T., & Shian, L. R. (1985). Thyrotropin-releasing hormone-induced hyperglycemia: Possible involvement of cholinergic receptors in the lateral hypothalamus. Neuroendocrinology, 41, 499–503.
Szabo, O., & Szabo, A. J. (1972). Evidence for an insulin-sensitive receptor in the central nervous system. American Journal of Physiology, 223, 1349–1353.
Szabo, A. J., & Szabo, O. (1975). Influence of the insulin sensitive central nervous system glucoregulator receptor on hepatic glucose metabolism. Journal of Physiology, 253, 121–133.
Szabo, A. J., & Szabo, O. (1983). Insulin injected into CNS structures or into the carotid artery: Effect on carbohydrate homeostasis of the intact animal. Advances in Metabolic Disorders, 10, 385–400.
Usman, A., & Koray, Z. (1984). The effect of thyrotropin-releasing hormone (TRH) on the peripheral plasma levels of pancreatic glucagon and insulin in man. Hormone Metabol. Research, 16, 263–264.
Usman, A., & Istanbullu, S. (1986). Lack of effect of thyrotropin- releasing hormone (TRH) on the peripheral plasma levels of pancreatic glucagon in man. Hormone Metabol. Research, 18, 256–259.
Vranic, M., Gauthier, C, Bilinski, D., Wasserman, D., El Tayeb, K., Hetenyi, G., & Lickley, H. L. A. (1984). Catecholamine responses and their interactions with other glucoregulatory hormones. American Journal of Physiology, 247, E145-E156.
Wood, S. M., Polak, J. M, & Bloom, S. R. (1983). Neuropeptides in the control of the islets of Langerhans. Advances in Metabolic Disorders, 10, 401–420.
Yarbrough, G. G. (1979). On the neuropharmacology of thyrotropin- releasing hormone (TRH). Progress in Neurobiology, 12, 291–312.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Kluwer Academic Publishers
About this chapter
Cite this chapter
Amir, S., Pollock, R. (1990). Counterregulation of Stress-Induced Hyperglycemia by Thyrotropin-Releasing Hormone. In: Puglisi-Allegra, S., Oliverio, A. (eds) Psychobiology of Stress. NATO ASI Series, vol 54. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1990-7_12
Download citation
DOI: https://doi.org/10.1007/978-94-009-1990-7_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7390-5
Online ISBN: 978-94-009-1990-7
eBook Packages: Springer Book Archive